Compare NOC & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOC | BMY |
|---|---|---|
| Founded | 1939 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.9B | 95.0B |
| IPO Year | N/A | N/A |
| Metric | NOC | BMY |
|---|---|---|
| Price | $572.49 | $49.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 11 |
| Target Price | ★ $642.73 | $55.64 |
| AVG Volume (30 Days) | 730.8K | ★ 14.5M |
| Earning Date | 10-21-2025 | 10-30-2025 |
| Dividend Yield | 1.61% | ★ 5.04% |
| EPS Growth | ★ 73.89 | N/A |
| EPS | ★ 27.81 | 2.97 |
| Revenue | $40,928,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $3.09 | N/A |
| Revenue Next Year | $5.35 | N/A |
| P/E Ratio | $20.58 | ★ $16.56 |
| Revenue Growth | N/A | ★ 1.26 |
| 52 Week Low | $426.24 | $42.52 |
| 52 Week High | $640.90 | $63.33 |
| Indicator | NOC | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 64.84 |
| Support Level | $560.00 | $45.27 |
| Resistance Level | $582.60 | $49.50 |
| Average True Range (ATR) | 9.22 | 1.14 |
| MACD | 1.83 | 0.19 |
| Stochastic Oscillator | 67.68 | 83.17 |
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.